Form 4 for LLY Lilly (Eli)
Accepted 2022-06-02 00:00:00 ET · period of report 2022-06-01 · accession 0000059478-22-000161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-02 | 2022-06-01 | LLY | Rau Diogo | SVP, CIDO | M - OptEx | $0.00 | +7,560 | 7,560 | New | $0 |
| D | 2022-06-02 | 2022-06-01 | LLY | Rau Diogo | SVP, CIDO | F - Tax | $313.44 | -3,166 | 4,394 | -42% | -$992.4K |
| D | 2022-06-02 | 2022-06-01 | LLY | Rau Diogo | SVP, CIDO | M - OptEx | $0.00 | -7,560 | 12.6K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | M | A | 7,560 | $0.00 | 7,560 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-01 | F | D | 3,166 | $313.44 | 4,394 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-06-01 | M | D | 7,560 | $0.00 | 12,600 | D | — · — to — | 7,560 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. (F2) The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. |